In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.
Haematologica
; 95(5): 794-803, 2010 May.
Article
in En
| MEDLINE
| ID: mdl-19951978
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Multiple Myeloma
Type of study:
Clinical_trials
Limits:
Animals
/
Humans
Language:
En
Journal:
Haematologica
Year:
2010
Type:
Article
Affiliation country:
Spain